Showing 3,241 - 3,260 results of 9,774 for search 'significantly ((((((linear decrease) OR (larger decrease))) OR (we decrease))) OR (mean decrease))', query time: 0.64s Refine Results
  1. 3241

    Data used to generate Table 5. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…Our results showed that an irradiation dose of 7 Gy significantly caused more than 90% sterility in both wild-type males and females (<i>p</i> < 0.05). …”
  2. 3242

    Data used to generate Table 3. by Pattamaporn Kittayapong (289542)

    Published 2025
    “…Our results showed that an irradiation dose of 7 Gy significantly caused more than 90% sterility in both wild-type males and females (<i>p</i> < 0.05). …”
  3. 3243
  4. 3244

    Multiple comparisons after ANOVA(CR10). by Xinyu Dai (5100731)

    Published 2025
    “…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
  5. 3245

    Homogeneity test of CR10. by Xinyu Dai (5100731)

    Published 2025
    “…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
  6. 3246

    Illustration of the fNIRS device worn. by Xinyu Dai (5100731)

    Published 2025
    “…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
  7. 3247

    Analysis of variance of HbO<sub>2</sub> in bilateral PFC. by Xinyu Dai (5100731)

    Published 2025
    “…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
  8. 3248

    fNIRS equipment coordinates. by Xinyu Dai (5100731)

    Published 2025
    “…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
  9. 3249

    Changes of muscle oxygen saturation. by Xinyu Dai (5100731)

    Published 2025
    “…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
  10. 3250

    Analysis of variance of CR10. by Xinyu Dai (5100731)

    Published 2025
    “…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
  11. 3251

    Placement on the forehead. by Xinyu Dai (5100731)

    Published 2025
    “…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
  12. 3252

    IMW intervention plan design. by Xinyu Dai (5100731)

    Published 2025
    “…Post hoc analysis demonstrated significantly decreased HbO₂ in both the IMW (<i>p</i> = 0.019) and placebo (<i>p</i> = 0.035) groups relative to blank controls. …”
  13. 3253
  14. 3254
  15. 3255

    Risk of bias across 22 included studie. by Kuo-Chuan Hung (8587392)

    Published 2024
    “…</p><p>Results</p><p>A meta-analysis of 22 RCTs (n = 3,463) showed that ketamine/esketamine significantly decreased PPD risk at 1- (risk ratio [RR], 0.41; 95% confidence interval [CI], 0.3–0.57) and 4–6-week (RR, 0.47; 95%CI, 0.35–0.63) follow-ups. …”
  16. 3256

    An overview of the selection process for studies. by Kuo-Chuan Hung (8587392)

    Published 2024
    “…</p><p>Results</p><p>A meta-analysis of 22 RCTs (n = 3,463) showed that ketamine/esketamine significantly decreased PPD risk at 1- (risk ratio [RR], 0.41; 95% confidence interval [CI], 0.3–0.57) and 4–6-week (RR, 0.47; 95%CI, 0.35–0.63) follow-ups. …”
  17. 3257

    Characteristics of studies (<i>n</i> = 22). by Kuo-Chuan Hung (8587392)

    Published 2024
    “…</p><p>Results</p><p>A meta-analysis of 22 RCTs (n = 3,463) showed that ketamine/esketamine significantly decreased PPD risk at 1- (risk ratio [RR], 0.41; 95% confidence interval [CI], 0.3–0.57) and 4–6-week (RR, 0.47; 95%CI, 0.35–0.63) follow-ups. …”
  18. 3258
  19. 3259

    Reversible Small Molecule Multivariant Ras Inhibitors Display Tunable Affinity for the Active and Inactive Forms of Ras by Charles W. Parry (20966154)

    Published 2025
    “…Here we report the discovery of a novel series of reversible inhibitors that bind in an enlarged version of the switch I–II pocket with nanomolar affinities. …”
  20. 3260